
The UK competition regulator has launched enforcement cases into Ryanair and British Airways after the airlines refused to offer customers refunds for flights they were unable to take during the pandemic, reported The Financial Times.
The announcement on Wednesday, June 9, by the Competition and Markets Authority (CMA) brought a furious response from BA, which stated the investigation was “incredible” and any punishment could put jobs at risk.
The CMA stated it was investigating whether BA and Ryanair had broken consumer protection law and had written to both companies detailing its concerns. The regulator opened the probe in December.
During the pandemic, when customers were unable to fly because of lockdowns in the UK, BA offered customers vouchers or the chance to rebook their flights and Ryanair only provided the option to rebook.
Andrea Coscelli, chief executive of the CMA, said, “While we understand that airlines have had a tough time during the pandemic, people should not be left unfairly out of pocket for following the law. “Customers booked these flights in good faith and were legally unable to take them due to circumstances entirely outside of their control. We believe these people should have been offered their money back.”
The investigation is a new headache for BA and Ryanair as the airline industry faces the growing prospect of a second lost summer of travel.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas